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Abstract
This paper deals with aneurysmal disease, primarily when localized in the abdominal aorta. It is based on the Olof Rudbeck
lecture 2009. Aneurysm is a localized widening of an artery, and its deﬁnition has become an important issue today when the
disease is in focus for screening programmes. Aetiology and pathogenesis are still poorly understood, but a genetic component
determining the strength of the aortic wall is important, and there is a strong male dominance. Historically, several attempts
have been made to treat the disease, but reconstructive treatment has been possible only since 1951, in an increasing number of
cases performed endovascularly. By early detection through screening, and thereby the possibility to treat before rupture, it has
now become possible to decrease the total mortality from the disease in the population.
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Aneurysmal disease continues to fascinate people––
both professionals and laymen. There are certainly
several reasons, but two important ones are that in the
majority of cases the disease is asymptomatic but with
an inherent risk to rupture, when it becomes dramatic
and often ends with the patient’s death––from no
symptoms to a life-threatening condition within min-
utes to hours. Intuitively it therefore seems logical to
detect the aneurysm and treat it before rupture. This
paper will review the aneurysmal disease from a
historical perspective with special emphasis on aneur-
ysms in the abdominal aorta (triple A or AAA). The
term abdominal aortic aneurysm is a linguistic mix-
ture of Greek (aneurynein, to widen; aeirein, to heave)
and Latin (abdomen, stomach).
Deﬁnition
There have been various deﬁnitions over time from
the morphological appearance of a bulging artery to
diameter measures in absolute terms and to aneurysm
diameter in relation to the patient’s non-aneurysmal
aorta or to an ideal diameter obtained from
nomograms (1). The deﬁnition was hardly a
problem previously, when aneurysms were diagnosed
because of symptoms, when they were large and
therefore easily diagnosed even clinically. The deﬁ-
nition has become an important issue when screening
is discussed, where aneurysms of all sizes are detected
and also very small ones have to be dealt with
(Figure 1).
Before 1900
From antique times until the 1800s the majority of
aneurysms were traumatic in origin, and they were
also the easiest to diagnose (a review of history in
more detail in reference (2)). Already in the Syna-
gogue Medica, Oribasius from Pergamon (325–403
AD) made the important classiﬁcation into true
(verum) and false (spurium) aneurysms in writing
‘there are two types of aneurysms: the ﬁrst is due
to dilatation of the arteries and the second is caused by
rupture of the artery emptying blood into the tissues.
When an aneurysm is due to dilatation the form is
cylindrical, while the one caused by injury is round.’
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DOI: 10.3109/03009730903518480One important subgroup of false aneurysms was
those caused by blood-letting, when the artery was
mistakenly punctured instead of the vein, i.e. an early
type of iatrogenic vascular injuries. One such a case is
described in detail by Olof Acrel in his ‘Chirurgiske
Händelser’ from 1759 (3). The case was complicated,
with infection leading to heavy haemorrhage and the
patient’s death, despite ligation undertaken by Acrel.
The complication was well known with a couple of
cases every year at the ‘Seraﬁmer lazarettet’ where
Acrel was the head, and the consensus among sur-
geons at the time was to ligate and rely on the
collateral circulation to avoid ischaemia.
Another type of trauma was probably the cause of
an aneurysm reported by John Hunter. He described a
popliteal aneurysm in a coachman with repeated
trauma to the popliteal fossa. It is interesting to
note that before ligating such aneurysms Hunter
had carried out animal experiments in deer belonging
to the royal family in Richmond Park. He ligated the
external carotid artery in the neck resulting in chilling
of the antlers, but in a few days they had normal
temperature again and by injecting coloured resin into
the carotid artery he could visualize and demonstrate
the collateral circulation. Obviously, we do not know
whether the popliteal aneurysm of the coachman was
post-traumatic or if it had an infectious cause such as
lues, or perhaps a combination.
During the second half of the 1800s there were
some theories on the cause of aneurysms, such as
long-standing respiratory pauses, excessive copula-
tion, and wearing too tight collars as was usually
the case in army soldiers. By and by, however, two
other explanations became prevalent, namely infec-
tion and atherosclerosis. Although the mechanism
behind the infection was not clear, Sir William Osler,
among others, described what he called mycotic
aneurysms, so named because of the often bizarre
and mushroom-like morphologic appearance of
the aneurysm. As mentioned above, one cause of
mycotic aneurysm was syphilis, often localized in
the thoracic aorta and a frequent killer when rupture
occurred. Arteriosclerosis as a cause of aneurysms
was suggested because of the microscopic ﬁnding
of arteriosclerosis in the aneurysmal wall. In German
text-books there was a differentiation between
‘stenosierende und dilatierende Atherosclerose’, indicating
a common aetiologic background to occlusive and
aneurysmal disease!
The treatment of aneurysms until 1900 was basi-
cally ligature, often on both sides of the aneurysm.
This technique was also used to treat an abdominal
aortic aneurysm by Sir Astley Cooper in 1818, a
dramatic and large operation at the time, although
the patient survived only a couple of days. A more
reconstructive way of thinking was introduced by
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Figure 1. Schematic drawing of the aortic diameter during a lifetime.
82 D. BergqvistRudolph Matas in New Orleans, when he described
his technique of aneurysmorrhaphy (ﬁrst used 1888 in
a patient with a post-traumatic brachial aneurysm)
(4). The philosophy was to obliterate the aneurysmal
sack leaving a channel in the middle for the blood to
circulate.
1900 –1950
Around the end of the 19th century, there were a lot of
activities of importance for understanding and treat-
ment of vascular diseases, which means also for aneu-
rysmal disease. The Nobel Prize was awarded for the
detection of X-rays. Only a few years after the original
report in 1896 it was used for angiography. Anaesthe-
siology developed, making increasingly advanced
operations possible. Various graft materials were tried
to replace blood vessels. For example, Abbe in
New York (1896) used glass tubes experimentally in
the aorta of cats: functioning but hardly practical. To
replace a popliteal aneurysm in a patient, Goyanes in
Lisboausedareversedvein.Bloodtransfusionbecame
practicallypossible whenbloodgroupswere described
by Landsteiner, who was also awarded the Nobel
Prize. The third Nobel laureate during this period of
importance in this context was Alexis Carrel, who
systematically described the basic vascular surgical
technique, important for all types of vascular recon-
structions and organ transplantations.
During this period not much happened regarding
the pathophysiological understanding of the aneurys-
mal disease, the dominating cause being considered
arteriosclerosis.
Regardingtreatment,ligaturewasstillused,although
this had as a prerequisite an adequate collateral circu-
lation, which was not always the case. Aneurysmorrha-
phy had come to stay, and among others Matas himself
in1942reporteda largepersonal experienceoftreating
aneurysms. Another therapeutic attempt was to induce
thrombotic occlusion, most often done by inserting a
foreign material into the aneurysmal sack, such as
metallic wires, sometimes also used to stimulate coag-
ulationbyanelectriccurrent.Moreorlesssophisticated
instrumentation was invented to reach the goal of
thrombotic occlusion. Unfortunately intra-aneurysmal
thrombosis did not prevent rupture.
Knowing that the size of the aneurysm and its
expansion were important to predict rupture, a logical
treatment step was to try to stabilize the wall and
prevent expansion. This was done using various types
of material, both synthetic (such as plastic ﬁlms and
cellulose) and biological (such as fascia). Whether this
method slowed down the expansion rate is not known,
but it did not prevent rupture. The most famous
illustration of this is Albert Einstein, whose aneurysm
was wrapped in 1948 by the well known New York
surgeon Rudolph Nissen, but Einstein’s death in 1955
was due to rupture.
1950 –1998 (United Kingdom Small
Aneurysm Trial)
Around 1950 the professional discussion had started
whether or not it was possible to reconstruct the aorta
instead of resecting it, which had been recommended
and used by René Leriche in case of occlusive disease.
Such a reconstruction with a homograft was carried
out by Oudot in 1951, and in the same year patients
with AAA were also surgically treated. The ﬁrst
two can be attributed to Norman Freeman in San
Francisco, the ﬁrst patient bleeding to death shortly
after the operation, the second with long-term survival
(5). Freeman used an inlay technique with a vein graft
to obtain circulation. A month later, Dubost (6) in
Paris resected an AAA using a homograft for recon-
struction in a similar way as Oudot (7). Soon synthetic
materials were used for the reconstruction (8), and
operationforrupturewithsurvivalwasintroduced(9).
Operating on patients with an asymptomatic disease
topreventastatistical risk forrupturehad toshowvery
low mortality and complication rates. This surgical
method rapidly spread, and publications soon
appeared with a postoperative survival only slightly
inferior to that of a matched normal population.
ThenextstepinhowtotreatpatientswithAAAcame
in 1986 when Nicolai Volodos in Ukraine used stent-
graft reconstruction, and in 1988 he used a similar
method to treat thoracic aortic aneurysm. Unfortu-
nately his ﬁrst two publications were in Russian and
therefore largely unknown outside the Soviet Union.
A similar method was used by Juan Parodi (10), and
although Volodos published an English report in 1991
inVasa(11),itwasthepaperby Parodiincombination
with his move from Argentina to the US which
hadagreatimpactonhowtotreatAAAendovascularly.
The method was attractive avoiding a large intraperi-
toneal operation, and the technology spread rapidly
although not properly evaluated.
During this period data accumulated questioning
that AAA is a manifestation of atherosclerosis. Prob-
ably the process is more complex, atherosclerosis
coming in rather late in the natural course of the
aneurysmal disease. It could well be that the devel-
opment of aneurysm is a common pathologic
response to various types of inﬂuences on the arterial
wall, some of them being summarized in Figure 2. In
many cases it has become evident that there is an
inborn defect in the strength of the aortic wall (col-
lagen and/or elastin), with an inherited pattern. So
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high prevalence of AAA (12). Better understanding of
the biology of AAA will certainly inﬂuence how to
design studies in the future with the aim to prevent
AAA or at least to slow down expansion rate once they
have occurred.
Data also started to appear on the epidemiology of
AAA. Age and gender are the most important factors
inﬂuencing the prevalence (Figure 3). There may also
be some geographical differences (Table I). Table II
shows the most important risk factors for AAA. Some
of them are also risk factors for complications and
mortality in relation to surgical treatment. Although
there has been an increase in elective surgery for AAA,
the rate of rupture has not decreased to a similar
extent or even increased (13), indicating a problem
in selecting the correct patients for surgery.
From 1998 onwards
This period can also be called the era of evidence-
based medicine, because during this period some
of the very important randomized trials in vas-
cular surgery have been published and certainly
inﬂuenced our ways of treating patients with vascular
disorders.
The aneurysmal size at which to contemplate sur-
gical treatment has been set to 55 mm (14,15). In
patients with an aneurysm diameter of 4.0–5.5 cm in
diameter, surveillance and early prophylactic elective
surgery have similar survival beneﬁts. However, after
8 years, total mortality was lower in the early-surgery
group, probably due to beneﬁcial life-style changes,
especially concerning smoking (16). Similar results
came out from the ADAM trial (Aneurysm Detection
Abdominal aortic aneurysm
(etiology and pathogenesis)
Genetic defect
(elastin/collagen)
Inflammatory
reaction
Pathological proteolysis
(MMP+, plasmin+, cystatinC-)
Infectious process
(Chlamydia)
Hypoxia
(adventitial vasa vasorum)
Atherosclerosis (degeneration of
media, necrosis, plaques)
External factors
(smoking, Ca-blockade)
Thrombosis in the sac
(hypoxia, wall thinnening,
extracellular matrix degeneration)
Haemodynamic
stress (hypertension,
pulse wave reflexion)
Dilatation
Vessel wall
stiffness
Dilatation
Aneurysmal
development
Aneurysm
Figure 2. Factors inﬂuencing the development of an aortic aneurysm.
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two studies have been meta-analysed in a Cochrane
review (18).
In 2004 two randomized studies were published com-
paring open surgery with endovascular repair (EVAR) in
abdominal aneurysms larger than 5–5.5 cm in diameter.
Both showed a short-term beneﬁt for EVAR but con-
cluded that long-term results had to be awaited before
giving ﬁrm recommendations (19,20). In a Medicare
cohort study of 45,660 patients, these early results
have been veriﬁed, but late re-interventions were
more common after endovascular repair (21). Further
support for early beneﬁt in EVAR-treated patients is
given in a planned interim analysis from an on-going
American veterans administration (VA) trial (22).
The World Health Organization criteria for screen-
ing to be considered are summarized in Table III.
Most of them now seem to be fulﬁlled when it comes
to AAA (23). The most important ones are that
asymptomatic adult subjects can harbour potentially
life-threatening disorders, that the disease of interest
can be detected at an early stage with a methodology
that is safe and accepted, and that discovery of the
disease can lead to some form of treatment, which
positively inﬂuences the patients’ survival and/or mor-
bidity. Large randomized trials on screening have now
been performed and also meta-analysed (24), showing
that aneurysm-related mortality can be reduced in the
population by introducing ultrasonographic screen-
ing. The mortality beneﬁt seems to be maintained at
least for 10 years (25). A recent publication from the
Swedish Board of Health Technology Assessment
recommends general screening of 65-year-old males,
and this is also cost-effective (26). This policy has
been introduced in several Swedish counties, and at
the moment of preparing this article screening covers
about 80% of the Swedish population. Whether or not
to screen 70-year-old females is dealt with in a
research project in Sweden at the moment.
Table I. Frequency of aneurysms in the abdominal aorta (AAA) in the general male population (ultrasonographic screening).
Attendance rate Age
Prevalence (%)
Author Reference Country (%)
a (years) Total >50 mm
Bengtsson (29) Malmö, Sweden 75 74 10.7 2.2
Scott (30) UK 59 65–80 7.6 1.0
Lederle (17) USA 30 50–79 4.6 0.5
Wanhainen (27) Norsjö, Sweden 91 65–75 17.3 4.8
Wanhainen Unpublished Uppsala, Sweden 84 65 3.3 0.5
aNumber attending the screening of those invited (in per cent).
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Figure 3. Sex-speciﬁc prevalence of abdominal aortic aneurysm conﬁrmed by necropsy (from Bengtsson et al. 1992 with permission (28)).
Table II. Risk factors for abdominal aortic aneurysm.
Male gender
Age
Smoking
Family history
Occlusive arterial disease
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consequences. A number of aneurysms will be
detected, some of them of a size where surgery can
be strongly recommended. This will hopefully
decrease the rupture rate and thereby the need for
emergency surgery, turning the acute cases into elec-
tive ones. Some problems will occur when detecting
small aneurysms, where the subjects will turn from
being healthy individuals to patients with a potentially
serious disease. They have to be included in a follow-
up programme and some, in case of increase in size,
may be offered surgical treatment. This obviously also
has ethical implications. One advantage (on a popu-
lation basis) is that the cohort of patients with small
aneurysms can be offered taking part in various ran-
domized trials investigating substances with the
potential to slow down aneurysmal expansion rate
with the ﬁnal aim to avoid the need for surgery and
the risk of rupture (Table IV).
Concluding remarks
That AAA is a disease known in the population as a
serious one is reﬂected in two recent Swedish pub-
lications. One is the autobiography ‘Viewing back’
from 2008 by the Professor of History of Ideas in
Gothenburg, Sven-Erik Liedman (31). He is writing
about his grandfather: ‘He was an optimist to the ﬁnal
end. When he was dying I sat by his side. The aorta
had ruptured when he was working in his garden
with stabilizing pea plants and in his uncon-
sciousness he continued with that.’ The other citation
is from ‘Dorés Bibel’ (2005) (32) by the member of
the Swedish Academy Torgny Lindgren, illustrating
a common knowledge in the population of the
Norsjö community, a knowledge that was veriﬁed
by ultrasonographic screening by Anders Wanhainen
(27): ‘We inhabitants in Norsjö have a peculiar
kind of aneurysms in our abdominal cavity, I said.
They tend to rupture, that is what is killing us.
This one was exceedingly larger than a varicosity,
Manfred said.’
This fascinating history of aneurysmal disease has
brought us to today’s screening programmes, which––
if they become largely accepted––will for the ﬁrst time
give us a very good way of decreasing the total
mortality ofaneurysmal disease within the population,
based on scientiﬁc evidence.
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